Public perspective toward extended community pharmacy services in sub-national Saudi Arabia: An online cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
12
2022
accepted:
17
09
2023
medline:
9
10
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
epublish
Résumé
In many developed countries, the scope of community pharmacy services has extended to include advanced applications. Unlike traditional practices that focus on pharmaceutical sales, extended community pharmacy services (ECPSs) are patient-centred and typically offered by specialised healthcare centres, which improve public health, reduce pressure imposed on healthcare professionals, and rationalise health system expenditures. However, based on the findings of several studies, community pharmacies (CPs) only provide marginalised services. Public reviews are thus crucial to effectively utilise such services. This study explored CPs use among the Saudi public in terms of knowledge, attitudes, and barriers to ECPSs. We conducted a cross-sectional web-based survey of a non-probability sample between October and December 2021. Numerical and graphical descriptive statistics were employed with an additional analytical assessment using binary logistic regression to determine the association between participant characteristics and the barriers to ECPSs use. A total of 563 individuals participated in this study, approximately 33% of which revealed CPs as the first place they visit for medication concerns. Most individuals were not aware of medication therapy management and health screening services (77% and 68%, respectively). Pharmacy clinics offering private counselling and receiving patient electronic medical records were unknown to the participants (78% and 63%, respectively). A substantial proportion of the cohort considered lack of privacy (58%) and inadequate communication with community pharmacists (56%) as key barriers to the use of ECPSs. Logistic regression analysis revealed that the underdeveloped infrastructure of CPs was significantly associated with almost all factors. Most services and facilities were found to be underutilised. Positive public attitudes were associated with concerns regarding privacy and cost of services. Consistent with Saudi Vision 2030, supporting CPs and increasing the public awareness of ECPSs have significant implications on public health.
Sections du résumé
BACKGROUND
In many developed countries, the scope of community pharmacy services has extended to include advanced applications. Unlike traditional practices that focus on pharmaceutical sales, extended community pharmacy services (ECPSs) are patient-centred and typically offered by specialised healthcare centres, which improve public health, reduce pressure imposed on healthcare professionals, and rationalise health system expenditures. However, based on the findings of several studies, community pharmacies (CPs) only provide marginalised services. Public reviews are thus crucial to effectively utilise such services. This study explored CPs use among the Saudi public in terms of knowledge, attitudes, and barriers to ECPSs.
MATERIALS AND METHODS
We conducted a cross-sectional web-based survey of a non-probability sample between October and December 2021. Numerical and graphical descriptive statistics were employed with an additional analytical assessment using binary logistic regression to determine the association between participant characteristics and the barriers to ECPSs use.
RESULTS
A total of 563 individuals participated in this study, approximately 33% of which revealed CPs as the first place they visit for medication concerns. Most individuals were not aware of medication therapy management and health screening services (77% and 68%, respectively). Pharmacy clinics offering private counselling and receiving patient electronic medical records were unknown to the participants (78% and 63%, respectively). A substantial proportion of the cohort considered lack of privacy (58%) and inadequate communication with community pharmacists (56%) as key barriers to the use of ECPSs. Logistic regression analysis revealed that the underdeveloped infrastructure of CPs was significantly associated with almost all factors.
CONCLUSION
Most services and facilities were found to be underutilised. Positive public attitudes were associated with concerns regarding privacy and cost of services. Consistent with Saudi Vision 2030, supporting CPs and increasing the public awareness of ECPSs have significant implications on public health.
Identifiants
pubmed: 37796778
doi: 10.1371/journal.pone.0280095
pii: PONE-D-22-34641
pmc: PMC10553341
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0280095Informations de copyright
Copyright: © 2023 Alghamdi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Can Pharm J (Ott). 2014 Jul;147(4):239-47
pubmed: 25360150
Risk Manag Healthc Policy. 2020 Jun 18;13:595-607
pubmed: 32607027
Pharm Pract (Granada). 2013 Oct;11(4):228-45
pubmed: 24367463
Saudi Pharm J. 2015 Jul;23(3):230-4
pubmed: 26106270
BMC Health Serv Res. 2021 Jul 4;21(1):649
pubmed: 34217293
Patient Prefer Adherence. 2011;5:405-22
pubmed: 21949604
Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):747-758
pubmed: 27828725
Pharm Pract (Granada). 2018 Apr-Jun;16(2):1126
pubmed: 30023022
Health Expect. 2018 Apr;21(2):409-428
pubmed: 29114971
J Pak Med Assoc. 2021 Mar;71(3):950-965
pubmed: 34057955
Saudi Med J. 2015 Mar;36(3):328-34
pubmed: 25737176
Health Expect. 2004 Sep;7(3):191-202
pubmed: 15327458
Risk Manag Healthc Policy. 2021 Apr 19;14:1615-1627
pubmed: 33907479
Health Soc Care Community. 2019 May;27(3):565-598
pubmed: 30047617
Saudi Pharm J. 2020 May;28(5):529-537
pubmed: 32435133
Int J Pharm Pract. 2018 Apr;26(2):120-128
pubmed: 28543969
Med Princ Pract. 2017;26(5):438-446
pubmed: 28934755
Vaccine. 2020 Jul 6;38(32):5009-5014
pubmed: 32540273
Int J Clin Pharm. 2018 Oct;40(5):1106-1115
pubmed: 29926256
BMC Health Serv Res. 2019 Mar 21;19(1):186
pubmed: 30898124
Res Social Adm Pharm. 2021 Aug;17(8):1373-1395
pubmed: 33257161
PLoS One. 2020 Apr 2;15(4):e0230863
pubmed: 32241021
Pharmacy (Basel). 2019 Aug 04;7(3):
pubmed: 31382690
Saudi Pharm J. 2012 Oct;20(4):323-30
pubmed: 23960807
J Taibah Univ Med Sci. 2016 Sep 06;12(3):273-275
pubmed: 31435251
Res Social Adm Pharm. 2021 Feb;17(2):362-367
pubmed: 32280050